We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

557 hedge funds and large institutions have $2.28B invested in iShares US Medical Devices ETF in 2023 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 124 increasing their positions, 264 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

173% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $4.8M

1.65% more ownership

Funds ownership: 36.43%38.08% (+1.6%)

5% less first-time investments, than exits

New positions opened: 58 | Existing positions closed: 61

3% less funds holding

Funds holding: 577557 (-20)

6% less funds holding in top 10

Funds holding in top 10: 1615 (-1)

17% less capital invested

Capital invested by funds: $2.75B → $2.28B (-$472M)

53% less repeat investments, than reductions

Existing positions increased: 124 | Existing positions reduced: 264

Holders
557
Holders Change
-20
Holders Change %
-3.47%
% of All Funds
8.88%
Holding in Top 10
15
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-6.25%
% of All Funds
0.24%
New
58
Increased
124
Reduced
264
Closed
61
Calls
$13.1M
Puts
$4.8M
Net Calls
+$8.32M
Net Calls Change
+$41.6M
Name Holding Trade Value Shares
Change
Change in
Stake
MA
226
Mezzasalma Advisors
New Jersey
$951K -$30.1K -566 -3%
P
227
&Partners
Tennessee
$937K -$17.6K -330 -2%
CIC
228
Carnegie Investment Counsel
Ohio
$922K -$184K -3,450 -17%
Vontobel Holding
229
Vontobel Holding
Switzerland
$921K -$213K -4,000 -19%
CAG
230
Csenge Advisory Group
Florida
$879K -$1.04M -19,547 -55%
EDRH
231
Edmond de Rothschild Holding
Switzerland
$878K +$812K +15,251 +1,495%
BFEC
232
Benjamin F. Edwards & Company
Missouri
$847K +$13.2K +247 +2%
BCA
233
Bay Colony Advisors
Massachusetts
$846K +$1.12K +21 +0.1%
TSWM
234
Triangle Securities Wealth Management
North Carolina
$846K -$2.13K -40 -0.3%
RIA
235
Regal Investment Advisors
Michigan
$841K +$30.7K +577 +4%
Lido Advisors
236
Lido Advisors
California
$835K +$102K +1,910 +14%
VFG
237
V2 Financial group
Illinois
$831K
CB
238
Commerce Bank
Missouri
$830K -$296K -5,564 -27%
USCWA
239
U.S. Capital Wealth Advisors
Texas
$825K +$178K +3,335 +28%
ACM
240
AlphaStar Capital Management
North Carolina
$812K -$5.64K -106 -0.8%
BBA
241
BLB&B Advisors
Pennsylvania
$803K +$54.1K +1,016 +7%
STA
242
Summit Trail Advisors
New York
$802K +$791K +14,866 New
CIAS
243
Capital Investment Advisory Services
North Carolina
$801K +$7.88K +148 +1%
NFG
244
Nations Financial Group
Iowa
$796K -$10.2K -191 -1%
IAIM
245
International Assets Investment Management
Florida
$786K -$36.3K -681 -4%
GVAG
246
Great Valley Advisor Group
Delaware
$782K -$114K -2,142 -13%
Brown Advisory
247
Brown Advisory
Maryland
$774K -$115K -2,162 -13%
GPA
248
Guerra Pan Advisors
New Jersey
$747K
VVP
249
Venture Visionary Partners
Ohio
$735K
TC
250
TownSquare Capital
Utah
$729K +$107K +2,008 +17%

IHI Hedge Fund Activity: Q1 2023 in Review

557 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q1 2023, worth a combined $2.28B — down 17% from $2.75B a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of IHI and 58 opened new positions — a net loss of 3 holders — while 264 trimmed existing stakes and 124 added.

The largest buyer was Menora Mivtachim Holdings, opening a new position worth an estimated $105M. The largest seller was AssetMark Inc, cutting an estimated $68.6M.

  • 557 institutional investors held iShares US Medical Devices ETF (IHI) as of Q1 2023, down from 577 in Q4 2022.
  • Funds reported $2.28B of iShares US Medical Devices ETF stock for Q1 2023, down 17% quarter-over-quarter.
  • 58 funds opened new iShares US Medical Devices ETF positions in Q1 2023 and 61 closed out, a net change of -3 holders.
  • The largest iShares US Medical Devices ETF buyer in Q1 2023 was Menora Mivtachim Holdings, an estimated $105M added.
  • The largest iShares US Medical Devices ETF seller in Q1 2023 was AssetMark Inc, an estimated $68.6M sold.

Based on aggregated 13F filings for Q1 2023.